Protective effects of arbutin against doxorubicin-induced cardiac damage.
Apoptosis
Arbutin
DNA/RNA damage
Doxorubicin
Inflammation
Oxidative stress
Journal
Molecular biology reports
ISSN: 1573-4978
Titre abrégé: Mol Biol Rep
Pays: Netherlands
ID NLM: 0403234
Informations de publication
Date de publication:
18 Apr 2024
18 Apr 2024
Historique:
received:
28
07
2023
accepted:
26
03
2024
medline:
19
4
2024
pubmed:
19
4
2024
entrez:
18
4
2024
Statut:
epublish
Résumé
Doxorubicin is an effective antineoplastic agent but has limited clinical application because of its cumulative toxicities, including cardiotoxicity. Cardiotoxicity causes lipid peroxidation, genetic impairment, oxidative stress, inhibition of autophagy, and disruption of calcium homeostasis. Doxorubicin-induced cardiotoxicity is frequently tried to be mitigated by phytochemicals, which are derived from plants and possess antioxidant, anti-inflammatory, and anti-apoptotic properties. Arbutin, a natural antioxidant found in the leaves of the bearberry plant, has numerous pharmacological benefits, including antioxidant, anti-bacterial, anti-hyperglycemic, anti-inflammatory, and anti-tumor activity. The study involved male Wistar rats divided into three groups: a control group, a group treated with doxorubicin (20 mg/kg) to induce cardiac toxicity, a group treated with arbutin (100 mg/kg) daily for two weeks before doxorubicin administration. After treatment, plasma and heart tissue samples were collected for analysis. The samples were evaluated for oxidative stress parameters, including superoxide dismutase, malondialdehyde, and catalase, as well as for cardiac biomarkers, including CK, CK-MB, and LDH. The heart tissues were also analyzed using molecular (TNF-α, IL-1β and Caspase 3), histopathological and immunohistochemical methods (8-OHDG, 4 Hydroxynonenal, and dityrosine). The results showed that arbutin treatment was protective against doxorubicin-induced oxidative damage by increasing SOD and CAT activity and decreasing MDA level. Arbutin treatment was similarly able to reverse the inflammatory response caused by doxorubicin by reducing TNF-α and IL-1β levels and also reverse the apoptosis by decreasing caspase-3 levels. It was able to prevent doxorubicin-induced cardiac damage by reducing cardiac biomarkers CK, CK-MB and LDH levels. In addition to all these results, histopathological analyzes also show that arbutin may be beneficial against the damage caused by doxorubicin on heart tissue. The study suggests that arbutin has the potential to be used to mitigate doxorubicin-induced cardiotoxicity in cancer patients.
Sections du résumé
BACKGROUND
BACKGROUND
Doxorubicin is an effective antineoplastic agent but has limited clinical application because of its cumulative toxicities, including cardiotoxicity. Cardiotoxicity causes lipid peroxidation, genetic impairment, oxidative stress, inhibition of autophagy, and disruption of calcium homeostasis. Doxorubicin-induced cardiotoxicity is frequently tried to be mitigated by phytochemicals, which are derived from plants and possess antioxidant, anti-inflammatory, and anti-apoptotic properties. Arbutin, a natural antioxidant found in the leaves of the bearberry plant, has numerous pharmacological benefits, including antioxidant, anti-bacterial, anti-hyperglycemic, anti-inflammatory, and anti-tumor activity.
METHODS AND RESULTS
RESULTS
The study involved male Wistar rats divided into three groups: a control group, a group treated with doxorubicin (20 mg/kg) to induce cardiac toxicity, a group treated with arbutin (100 mg/kg) daily for two weeks before doxorubicin administration. After treatment, plasma and heart tissue samples were collected for analysis. The samples were evaluated for oxidative stress parameters, including superoxide dismutase, malondialdehyde, and catalase, as well as for cardiac biomarkers, including CK, CK-MB, and LDH. The heart tissues were also analyzed using molecular (TNF-α, IL-1β and Caspase 3), histopathological and immunohistochemical methods (8-OHDG, 4 Hydroxynonenal, and dityrosine). The results showed that arbutin treatment was protective against doxorubicin-induced oxidative damage by increasing SOD and CAT activity and decreasing MDA level. Arbutin treatment was similarly able to reverse the inflammatory response caused by doxorubicin by reducing TNF-α and IL-1β levels and also reverse the apoptosis by decreasing caspase-3 levels. It was able to prevent doxorubicin-induced cardiac damage by reducing cardiac biomarkers CK, CK-MB and LDH levels. In addition to all these results, histopathological analyzes also show that arbutin may be beneficial against the damage caused by doxorubicin on heart tissue.
CONCLUSION
CONCLUSIONS
The study suggests that arbutin has the potential to be used to mitigate doxorubicin-induced cardiotoxicity in cancer patients.
Identifiants
pubmed: 38637360
doi: 10.1007/s11033-024-09488-4
pii: 10.1007/s11033-024-09488-4
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
532Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer Nature B.V.
Références
Carvalho C, Santos RX, Cardoso S, Correia S, Oliveira PJ, Santos MS, Moreira PI (2009) Doxorubicin: the good, the bad and the ugly effect. Curr Med Chem 16:3267–3285
pubmed: 19548866
doi: 10.2174/092986709788803312
Erfu C, Li L, Weiting Q, Tao C, Liwei M, Hemin Y, Junkun L (2024) Matrine attenuating cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity through improved mitochondrial membrane potential and activation of mitochondrial respiratory chain Complex I pathway. Biomed Pharmacother 173:116464
pubmed: 38503242
doi: 10.1016/j.biopha.2024.116464
Xu S, Zheng S, Ma N, Zhang H, Shi J, Huang J, Luo N, Wang M, Xiong Y (2024) Rhein potentiates doxorubicin in treating triple negative breast cancer by inhibiting cancer-associated fibroblasts. Biochem Pharmacol 223:116139
pubmed: 38499109
doi: 10.1016/j.bcp.2024.116139
Hao G, Yu Y, Gu B, Xing Y, Xue M (2015) Protective effects of berberine against doxorubicin-induced cardiotoxicity in rats by inhibiting metabolism of doxorubicin. Xenobiotica 45:1024–1029
pubmed: 25970816
doi: 10.3109/00498254.2015.1034223
Olson RD, Boerth RC, Gerber JG, Nies AS (1981) Mechanism of adriamycin cardiotoxicity: evidence for oxidative stress. Life Sci 29:1393–1401
pubmed: 7029182
doi: 10.1016/0024-3205(81)90001-1
Octavia Y, Tocchetti CG, Gabrielson KL, Janssens S, Crijns HJ, Moens AL (2012) Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies. J Mol Cell Cardiol 52:1213–1225
pubmed: 22465037
doi: 10.1016/j.yjmcc.2012.03.006
Benzer F, Kandemir FM, Ozkaraca M, Kucukler S, Caglayan C (2018) Curcumin ameliorates doxorubicin-induced cardiotoxicity by abrogation of inflammation, apoptosis, oxidative DNA damage, and protein oxidation in rats. J Biochem Mol Toxicol, 32
Deepa PR, Varalakshmi P (2005) Biochemical evaluation of the inflammatory changes in cardiac, hepatic and renal tissues of adriamycin-administered rats and the modulatory role of exogenous heparin-derivative treatment. Chem Biol Interact 156:93–100
pubmed: 16154121
doi: 10.1016/j.cbi.2005.07.008
Wang T, Xing G, Fu T, Ma Y, Wang Q, Zhang S, Chang X, Tong Y (2024) Role of mitochondria in doxorubicin-mediated cardiotoxicity: from molecular mechanisms to therapeutic strategies. Cell Stress Chaperones
QuanJun Y, GenJin Y, LiLi W, YongLong H, Yan H, Jie L, JinLu H, Jin L, Run G, Cheng G (2017) Protective effects of Dexrazoxane against Doxorubicin-Induced cardiotoxicity: a metabolomic study. PLoS ONE 12:e0169567
pubmed: 28072830
pmcid: 5224977
doi: 10.1371/journal.pone.0169567
Bosman M, Kruger DN, Favere K, De Meyer GRY, Franssen C, Van Craenenbroeck EM, Guns PJ (2023) Dexrazoxane does not mitigate early vascular toxicity induced by doxorubicin in mice. PLoS ONE 18:e0294848
pubmed: 38015959
pmcid: 10684076
doi: 10.1371/journal.pone.0294848
Yu X, Ruan Y, Huang X, Dou L, Lan M, Cui J, Chen B, Gong H, Wang Q, Yan M, Sun S, Qiu Q, Zhang X, Man Y, Tang W, Li J, Shen T (2020) Dexrazoxane ameliorates doxorubicin-induced cardiotoxicity by inhibiting both apoptosis and necroptosis in cardiomyocytes. Biochem Biophys Res Commun 523:140–146
pubmed: 31837803
doi: 10.1016/j.bbrc.2019.12.027
Abushouk AI, Ismail A, Salem AMA, Afifi AM, Abdel-Daim MM (2017) Cardioprotective mechanisms of phytochemicals against doxorubicin-induced cardiotoxicity. Biomed Pharmacother 90:935–946
pubmed: 28460429
doi: 10.1016/j.biopha.2017.04.033
Abdel-Daim MM, Kilany OE, Khalifa HA, Ahmed AAM (2017) Allicin ameliorates doxorubicin-induced cardiotoxicity in rats via suppression of oxidative stress, inflammation and apoptosis. Cancer Chemother Pharmacol 80:745–753
pubmed: 28785995
doi: 10.1007/s00280-017-3413-7
Sugier P, Seczyk L, Sugier D, Krawczyk R, Wojcik M, Czarnecka J, Okon S, Plak A (2021) Chemical characteristics and antioxidant activity of Arctostaphylos uva-ursi L. Spreng. At the Southern Border of the geographical range of the species in Europe. Molecules, 26
Migas P, Krauze-Baranowska M (2015) The significance of arbutin and its derivatives in therapy and cosmetics. Phytochem Lett 13:35–40
doi: 10.1016/j.phytol.2015.05.015
Ahmadian SR, Ghasemi-Kasman M, Pouramir M, Sadeghi F (2019) Arbutin attenuates cognitive impairment and inflammatory response in pentylenetetrazol-induced kindling model of epilepsy. Neuropharmacology 146:117–127
pubmed: 30503994
doi: 10.1016/j.neuropharm.2018.11.038
Nalban N, Sangaraju R, Alavala S, Mir SM, Jerald MK, Sistla R (2020) Arbutin attenuates Isoproterenol-Induced Cardiac Hypertrophy by inhibiting TLR-4/NF-kappaB pathway in mice. Cardiovasc Toxicol 20:235–248
pubmed: 31485892
doi: 10.1007/s12012-019-09548-3
Lv X, Zhu Y, Deng Y, Zhang S, Zhang Q, Zhao B, Li G (2020) Glycyrrhizin improved autophagy flux via HMGB1-dependent Akt/mTOR signaling pathway to prevent doxorubicin-induced cardiotoxicity. Toxicology 441:152508
pubmed: 32525084
doi: 10.1016/j.tox.2020.152508
Seyedan AA, Dezfoulian O, Alirezaei M (2020) Satureja Khuzistanica Jamzad essential oil prevents doxorubicin-induced apoptosis via extrinsic and intrinsic mitochondrial pathways. Res Pharm Sci 15:481–490
pubmed: 33628290
pmcid: 7879789
doi: 10.4103/1735-5362.297851
Khadir F, Pouramir M, Joorsaraee SG, Feizi F, Sorkhi H, Yousefi F (2015) The effect of arbutin on lipid peroxidation and antioxidant capacity in the serum of cyclosporine-treated rats. Casp J Intern Med 6:196–200
Demir EA, Demir S, Kazaz IO, Kucuk H, Alemdar NT, Buyuk A, Mentese A, Aliyazicioglu Y (2023) Arbutin abrogates testicular ischemia/reperfusion injury in rats through repression of inflammation and ER stress. Tissue Cell 82:102056
pubmed: 36921493
doi: 10.1016/j.tice.2023.102056
Ahiskali I, Ferah Okkay I, Mammadov R, Okkay U, Keskin Cimen F, Kurt N, Suleyman H (2021) Effect of taxifolin on cisplatin-associated oxidative optic nerve damage in rats. Cutan Ocul Toxicol 40:1–6
pubmed: 33121287
doi: 10.1080/15569527.2020.1844726
Okkay U, Ferah Okkay I, Aydin IC, Bayram C, Ertugrul MS, Gezer A, Hacimuftuoglu A (2021) Effects of Achillea millefolium on cisplatin induced ocular toxicity: an experimental study. Cutan Ocul Toxicol 40:214–220
pubmed: 34180746
doi: 10.1080/15569527.2021.1919137
Ferah Okkay I, Okkay U, Cicek B, Yilmaz A, Yesilyurt F, Mendil AS, Hacimuftuoglu A (2021) Neuroprotective effect of bromelain in 6-hydroxydopamine induced in vitro model of Parkinson’s disease. Mol Biol Rep 48:7711–7717
pubmed: 34643923
doi: 10.1007/s11033-021-06779-y
Ferah Okkay I, Okkay U, Gundogdu OL, Bayram C, Mendil AS, Ertugrul MS, Hacimuftuoglu A (2022) Syringic acid protects against thioacetamide-induced hepatic encephalopathy: behavioral, biochemical, and molecular evidence. Neurosci Lett 769:136385
pubmed: 34871743
doi: 10.1016/j.neulet.2021.136385
Okkay U, Ferah Okkay I, Cicek B, Aydin IC, Ozkaraca M (2022) Hepatoprotective and neuroprotective effect of taxifolin on hepatic encephalopathy in rats. Metab Brain Dis 37:1541–1556
pubmed: 35298730
doi: 10.1007/s11011-022-00952-3
Berthiaume JM, Wallace KB (2007) Adriamycin-induced oxidative mitochondrial cardiotoxicity. Cell Biol Toxicol 23:15–25
pubmed: 17009097
doi: 10.1007/s10565-006-0140-y
Ahmed HH, Mannaa F, Elmegeed GA, Doss SH (2005) Cardioprotective activity of melatonin and its novel synthesized derivatives on doxorubicin-induced cardiotoxicity. Bioorg Med Chem 13:1847–1857
pubmed: 15698802
doi: 10.1016/j.bmc.2004.10.066
De Beer EL, Bottone AE, Voest EE (2001) Doxorubicin and mechanical performance of cardiac trabeculae after acute and chronic treatment: a review. Eur J Pharmacol 415:1–11
pubmed: 11245845
doi: 10.1016/S0014-2999(01)00765-8
Ascensao A, Magalhaes J, Soares JM, Ferreira R, Neuparth MJ, Marques F, Oliveira PJ, Duarte JA (2005) Moderate endurance training prevents doxorubicin-induced in vivo mitochondriopathy and reduces the development of cardiac apoptosis. Am J Physiol Heart Circ Physiol 289:H722–731
pubmed: 15792986
doi: 10.1152/ajpheart.01249.2004
Zhou N, Zeng MN, Li K, Yang YY, Bai ZY, Zheng XK, Feng WS (2018) An integrated metabolomic strategy for the characterization of the effects of Chinese yam and its three active components on septic cardiomyopathy. Food Funct 9:4989–4997
pubmed: 30187904
doi: 10.1039/C8FO00688A
Dong Q, Chen L, Lu Q, Sharma S, Li L, Morimoto S, Wang G (2014) Quercetin attenuates doxorubicin cardiotoxicity by modulating Bmi-1 expression. Br J Pharmacol 171:4440–4454
pubmed: 24902966
pmcid: 4209150
doi: 10.1111/bph.12795
Raskovic A, Stilinovic N, Kolarovic J, Vasovic V, Vukmirovic S, Mikov M (2011) The protective effects of silymarin against doxorubicin-induced cardiotoxicity and hepatotoxicity in rats. Molecules 16:8601–8613
pubmed: 21993249
pmcid: 6264541
doi: 10.3390/molecules16108601
Yilmaz S, Atessahin A, Sahna E, Karahan I, Ozer S (2006) Protective effect of lycopene on adriamycin-induced cardiotoxicity and nephrotoxicity. Toxicology 218:164–171
pubmed: 16325981
doi: 10.1016/j.tox.2005.10.015
Hwang S, Kim SH, Yoo KH, Chung MH, Lee JW, Son KH (2022) Exogenous 8-hydroxydeoxyguanosine attenuates doxorubicin-induced cardiotoxicity by decreasing pyroptosis in H9c2 cardiomyocytes. BMC Mol Cell Biol 23:55
pubmed: 36517746
pmcid: 9753270
doi: 10.1186/s12860-022-00454-1
Uchida K (2003) 4-Hydroxy-2-nonenal: a product and mediator of oxidative stress. Prog Lipid Res 42:318–343
pubmed: 12689622
doi: 10.1016/S0163-7827(03)00014-6
Dadgar M, Pouramir M, Dastan Z, Ghasemi-Kasman M, Ashrafpour M, Moghadamnia AA, Khafri S, Pourghasem M (2018) Arbutin attenuates behavioral impairment and oxidative stress in an animal model of Parkinson’s disease. Avicenna J Phytomed 8:533–542
pubmed: 30456201
pmcid: 6235658
Takebayashi J, Ishii R, Chen J, Matsumoto T, Ishimi Y, Tai A (2010) Reassessment of antioxidant activity of arbutin: multifaceted evaluation using five antioxidant assay systems. Free Radic Res 44:473–478
pubmed: 20166881
doi: 10.3109/10715761003610760
Mohajeri M, Sahebkar A (2018) Protective effects of curcumin against doxorubicin-induced toxicity and resistance: a review. Crit Rev Oncol Hematol 122:30–51
pubmed: 29458788
doi: 10.1016/j.critrevonc.2017.12.005
Zhang J, Cui L, Han X, Zhang Y, Zhang X, Chu X, Zhang F, Zhang Y, Chu L (2017) Protective effects of tannic acid on acute doxorubicin-induced cardiotoxicity: involvement of suppression in oxidative stress, inflammation, and apoptosis. Biomed Pharmacother 93:1253–1260
pubmed: 28738542
doi: 10.1016/j.biopha.2017.07.051
Safari H, Zabihi E, Pouramir M, Morakabati P, Abedian Z, Karkhah A, Nouri HR (2020) Decrease of intracellular ROS by arbutin is associated with apoptosis induction and downregulation of IL-1 beta and TNF-alpha in LNCaP; prostate cancer. J Food Biochem, 44
Lee HJ, Kim KW (2012) Anti-inflammatory effects of arbutin in lipopolysaccharide-stimulated BV2 microglial cells. Inflamm Res 61:817–825
pubmed: 22487852
doi: 10.1007/s00011-012-0474-2
Childs AC, Phaneuf SL, Dirks AJ, Phillips T, Leeuwenburgh C (2002) Doxorubicin treatment in vivo causes cytochrome c release and cardiomyocyte apoptosis, as well as increased mitochondrial efficiency, superoxide dismutase activity, and Bcl-2: Bax ratio. Cancer Res 62:4592–4598
pubmed: 12183413
Asensio-Lopez MC, Soler F, Sanchez-Mas J, Pascual-Figal D, Fernandez-Belda F, Lax A (2016) Early oxidative damage induced by doxorubicin: source of production, protection by GKT137831 and effect on ca(2+) transporters in HL-1 cardiomyocytes. Arch Biochem Biophys 594:26–36
pubmed: 26906075
doi: 10.1016/j.abb.2016.02.021
Ma C, Zhang D, Ma Q, Liu Y, Yang Y (2021) Arbutin inhibits inflammation and apoptosis by enhancing autophagy via SIRT1. Adv Clin Exp Med 30:535–544
pubmed: 33974755
doi: 10.17219/acem/133493